Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a.
Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis.
Screening for inhibitors of microglia to reduce neuroinflammation.
Restless legs syndrome in Iranian multiple sclerosis patients: a case-control study.
Neuromyelitis optica in a Ugandan woman: a case report.
A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis.
Carboxypeptidase N-deficient mice present with polymorphic disease phenotypes on induction of experimental autoimmune encephalomyelitis.
Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy.
Prevalence of neurological conditions across the continuum of care based on interRAI assessments.
Masquerading optic neuritis.
Pituitary-ovary axis and ovarian reserve in fertile women with multiple sclerosis: A pilot study.
A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
Fingolimod May Protect Neurons from Degeneration
Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy.
Correction: An Oriental Medicine, Hyungbangpaedok-San Attenuates Motor Paralysis in an Experimental Model of Multiple Sclerosis by Regulating the T Cell Response.
Dysfunction in Motor Coordination in Neonatal White Matter Injury Model without Apparent Neuron Loss.
Is malnutrition a problem for multiple sclerosis patients?
Glutamate Release Machinery Is Altered in the Frontal Cortex of Rats with Experimental Autoimmune Encephalomyelitis.
Clinical pharmacology of ponesimod, a selective S1P1 receptor modulator, after uptitration to supratherapeutic doses in healthy subjects.
Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps.
A pilot study on factors involved with work participation in the early stages of multiple sclerosis.
Modulating neurotoxicity through CX3CL1/CX3CR1 signaling.
Onion-shaped white matter disease?
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis.]
TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination.

Pages